相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhibition of NF-κB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats
S Gupta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
A phase 8 and pharmacologic trial of two schedules of the proteasome inhibitor, PS-341 (bortezomib ,velcade), in patients with advanced cancer
GK Dy et al.
CLINICAL CANCER RESEARCH (2005)
NF-κB activation is required for the development of cardiac hypertrophy in vivo
YH Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
AU Klingbeil et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Proteasome inhibition ablates activation of NF-κB in myocardial reperfusion and reduces reperfusion injury
J Pye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
IκB overexpression in cardiomyocytes prevents NF-κB translocation and provides cardioprotection in trauma
DL Carlson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Left ventricular mass change during treatment and outcome in patients with essential hypertension
MJ Koren et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Early clinical experience with the novel proteasome inhibitor PS-519
IM Shah et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes
NH Purcell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Prognostic implications of left ventricular hypertrophy
BA Vakili et al.
AMERICAN HEART JOURNAL (2001)
Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy
CJ Friddle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)